Research Webinars

Long and Post-Acute COVID-19


COVID-19 is a novel disease which is revealing unprecedented challenges. While many patients with symptoms fortunately can survive acute disease, a substantial cohort undergoes a sustained clinical picture, exhibiting a subacute stage or “long” COVID-19. While the etiology of subacute COVID-19 remains unclear, disturbed immune responses, viral persistence, neural cell damage may be possible mechanisms. Further a multidisciplinary approach is needed to treat those patients.

Luiz Eugênio Mello
Scientific Director, FAPESP 

Francisco Laurindo
Heart Institute, University of São Paulo School of Medicine

Regis Goulard Rosa
Moinho dos Ventos Hospital, Porto Alegre

Catherine Hough
Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University

Geraldo Busatto
Medical School, University of São Paulo (FMUSP)

Carolina Lucas
School of Medicine,Yale University


There will be no certificate/declaration of presence
for events broadcast on YouTube YouTube.

You can participate in a Q & A panel. Please, send your comments
and questions (in English or Portuguese) to live@fapesp.br.


Supported by: